Related by context. Frequent words. (Click for all words.) 61 Wyeth Ayerst 60 VP Exercises Options 60 Paid Lobbyist 60 Berlex Laboratories 59 FY# Q3 earnings 59 CEO Exercises Options 59 Analysts Upgrades Downgrades 59 Welcomes Analyst Initiation 59 CFO Exercises Options 58 quotes/comstock/# * 58 Eli Lily 58 Approaching Resistance 57 Hoffmann LaRoche 57 Inc. FY# Q3 57 PROFILE CO 57 Earnings Scorecard 57 Hoechst Marion Roussel 56 Bearish Pressure Building 56 Rhone Poulenc Rorer 56 Director Exercises Options 56 Esperion Therapeutics 56 AXYS Design Automation 55 Vicuron Pharmaceuticals 55 Bristol Meyers Squibb 55 Vytorin combines 55 4Q Profit Jumps 54 Posts 1Q 54 Nasdaq AMGN 54 Digene Corporation 54 Boehringer Mannheim 54 Premarket Roundup 54 Initiates Phase II 54 Posts 4Q Loss 54 Tibotec Pharmaceuticals Ltd. 53 Co MRK 53 Constella Group 53 Movers Roundup 53 Announces Organizational Changes 53 Abbot Laboratories 53 Inc.ā 53 Bayer HealthCare subsidiary 53 GlaxoSmithKline plc NYSE 53 Inc Morning Commentary 53 CEO Discusses Q1 53 Lexicon Genetics 53 #cv# [001] 53 Shareholders Approve Acquisition 53 2Q Profit Jumps 53 Corp. Nasdaq GENZ 53 Genentech GlaxoSmithKline 53 Nasdaq BIIB 53 Prestwick Pharmaceuticals 53 Nasdaq CRXL 52 TradeSignals 52 TAP Pharmaceuticals 52 Reliant Pharmaceuticals 52 Inc.â 52 Agios Pharmaceuticals 52 Astra Zeneca 52 See BioWorld Today 52 American Cyanamid 52 GlaxoSmithKline Bristol Myers 52 CureDM 52 Eyetech Pharmaceuticals 52 Conference Call TRANSCRIPT 52 Janssen Pharmaceutica 52 NYSE JNJ 52 Progenics Pharmaceuticals 52 By Michael Scarchilli 52 Posts 4Q Profit 51 Altana Pharma 51 Burroughs Wellcome 51 Presents Positive 51 Ciba Geigy 51 AstraZeneca Bristol Myers 51 Zeneca 51 Inc Therapeutic Competitors 51 Esperion Therapeutics Inc. 51 Upjohn Co. 51 Aventis Pharmaceuticals 51 Inovio clinical 51 Penwest Pharmaceuticals 51 including nutritionals devices 51 Janssen Pharmaceutical 51 Prempro combination 51 SmithKline 51 Discusses Q3 51 IDEC Pharmaceuticals 51 ALZA Corporation 51 Bayer CropScience LP 51 Therapeutic Competitors 51 Co Morning Commentary 51 Profit Dips 51 Hybritech 51 Par Pharmaceuticals 50 Zacks Earnings Preview 50 gets USFDA nod 50 AstraZeneca Pharmaceuticals 50 2Q Profit Rises 50 AstraZeneca PLC AZN 50 NV Organon